A detailed history of 1832 Asset Management L.P. transactions in Becton Dickinson & CO stock. As of the latest transaction made, 1832 Asset Management L.P. holds 198,743 shares of BDX stock, worth $45.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
198,743
Previous 185,267 7.27%
Holding current value
$45.3 Million
Previous $43.3 Million 10.67%
% of portfolio
0.09%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$221.47 - $242.41 $2.98 Million - $3.27 Million
13,476 Added 7.27%
198,743 $47.9 Million
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $32.7 Million - $35.7 Million
145,139 Added 361.69%
185,267 $43.3 Million
Q1 2024

May 14, 2024

SELL
$233.45 - $247.73 $817,308 - $867,302
-3,501 Reduced 8.02%
40,128 $9.93 Million
Q4 2023

Feb 13, 2024

BUY
$232.24 - $267.23 $1.94 Million - $2.24 Million
8,373 Added 23.75%
43,629 $10.6 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $8.99 Million - $10 Million
35,256 New
35,256 $9.11 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $521,835 - $580,785
-2,189 Reduced 5.63%
36,680 $9.68 Million
Q1 2023

May 12, 2023

SELL
$229.71 - $259.35 $711,641 - $803,466
-3,098 Reduced 7.38%
38,869 $9.62 Million
Q4 2022

Feb 14, 2023

SELL
$218.29 - $256.91 $525,205 - $618,125
-2,406 Reduced 5.42%
41,967 $10.7 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $745,701 - $3.86 Million
14,613 Added 49.1%
44,373 $9.89 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $2.77 Million - $3.24 Million
-11,782 Reduced 28.36%
29,760 $7.34 Million
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $3.51 Million - $3.89 Million
-14,390 Reduced 25.73%
41,542 $10.9 Million
Q4 2021

Feb 15, 2022

SELL
$230.08 - $250.94 $257 Million - $280 Million
-1,117,272 Reduced 95.23%
55,932 $14.3 Million
Q3 2021

Nov 15, 2021

SELL
$232.72 - $256.47 $15.3 Million - $16.9 Million
-65,844 Reduced 5.31%
1,173,204 $296 Million
Q2 2021

Aug 16, 2021

BUY
$232.65 - $254.58 $78.7 Million - $86.1 Million
338,366 Added 37.57%
1,239,048 $305 Million
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $19.5 Million - $21.6 Million
-84,066 Reduced 8.54%
900,682 $221 Million
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $180 Million - $199 Million
809,360 Added 461.47%
984,748 $244 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $27.3 Million - $35.1 Million
126,750 Added 260.6%
175,388 $40.1 Million
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $60,912 - $72,964
-277 Reduced 0.57%
48,638 $11.6 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $4.55 Million - $6.48 Million
-23,242 Reduced 32.21%
48,915 $11.3 Million
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $665,606 - $751,098
-2,815 Reduced 3.75%
72,157 $19.6 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $557,542 - $619,201
2,418 Added 3.33%
74,972 $18.8 Million
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $434 - $492
-2 Reduced -0.0%
72,554 $18.2 Million
Q1 2019

May 15, 2019

SELL
$206.05 - $248.17 $993,985 - $1.2 Million
-4,824 Reduced 6.23%
72,556 $17.9 Million
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $146 Million - $184 Million
-713,880 Reduced 90.22%
77,380 $17.3 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $89.3 Million - $98.1 Million
383,106 Added 93.86%
791,260 $207 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $73.2 Million - $82.3 Million
351,974 Added 626.51%
408,154 $98.1 Million
Q1 2018

May 15, 2018

BUY
$205.46 - $240.27 $1.2 Million - $1.4 Million
5,835 Added 11.59%
56,180 $12.2 Million
Q4 2017

Feb 14, 2018

SELL
$189.0 - $222.64 $40.1 Million - $47.2 Million
-211,965 Reduced 80.81%
50,345 $10.7 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $49 Million - $52.2 Million
262,310
262,310 $50.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.